Document type: drug_safety_update
There are 854 pages with document type ‘drug_safety_update’ in the GOV.UK search index.
Rendering apps
This document type is rendered by:
Supertypes
| Type | Group |
|---|---|
| User journey | thing |
| Email document type | other |
| Government document type | other |
| Content Purpose Subgroup | updates_and_alerts |
| Content Purpose Supergroup | news_and_communications |
Content schemas
This document type is allowed by the schema:
Example pages
- Mesalazine and idiopathic intracranial hypertension
- Aminoglycosides (gentamicin, amikacin, tobramycin, and neomycin): increased risk of deafness in patients with mitochondrial mutations
- Topiramate (Topamax): introduction of new safety measures, including a Pregnancy Prevention Programme
- Isotretinoin – updates to prescribing guidance and survey of services
- GLP-1 receptor agonists: reminder of the potential side effects and to be aware of the potential for misuse
- Citalopram and escitalopram: QT interval prolongation
- Quinine: not to be used routinely for nocturnal leg cramps
- Short-acting beta 2 agonists (SABA) (salbutamol and terbutaline): reminder of the risks from overuse in asthma and to be aware of changes in the SABA prescribing guidelines
- Metformin and reduced vitamin B12 levels: new advice for monitoring patients at risk
- Fluoroquinolone antibiotics: must now only be prescribed when other commonly recommended antibiotics are inappropriate